The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Chapter 11 cases

24 Feb 2023 07:00

RNS Number : 9187Q
Cineworld Group plc
24 February 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM THE UNITED STATES OF AMERICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

CINEWORLD GROUP PLC("Cineworld" or the "Company")

Update on Chapter 11 cases

Chapter 11 cases

On 7 September 2022, Cineworld (together with its subsidiaries, the "Group") announced that it and certain of its subsidiaries had commenced Chapter 11 cases in the United States. In that announcement, Cineworld stated its expectation that any transaction implemented through the Chapter 11 cases would result in very significant dilution of existing equity interests in the Group and that there was no guarantee of any recovery for holders of existing equity interests.

Since then, Cineworld has been in discussions with its key stakeholders with a view to developing as expeditiously as possible a plan of reorganisation (a "Plan") that maximises value for the benefit of moviegoers, the Group and all other stakeholders, taken as a whole, in the long term. As announced on 3 January 2023, in parallel with the discussions regarding a potential Plan, Cineworld has also been running a marketing process in pursuit of a value maximising transaction for the Group's assets (the "Marketing Process"). 

Further, in connection with the Marketing Process, the Company has now received non-binding proposals from a number of potential transaction counterparties for some or all of the Group's business. None of these proposals involves an all-cash bid for the entire business. The Company is reviewing such proposals in conjunction with its advisers and key stakeholders and, whilst no decision has been made as to whether to pursue a sale transaction, and the terms of any such transaction remain uncertain, based on the proposals received to date, it is not expected that any sale transaction will provide any recovery for the holders of the Company's equity interests. Any sale transaction for the Group as a whole would not include the sale of the equity interests in Cineworld itself and would therefore not be subject to the rules of the Takeover Code.

Discussions between the Company and certain of its stakeholders regarding a potential Plan are progressing. Whilst the discussions suggest that there is a route to the Company emerging from the Chapter 11 cases, in light of the level of existing debt that is expected to be released under any Plan, the Company does not believe that there will be sufficient creditor support for a Plan that contemplates any recovery for equity interests, and it is therefore not expected at this time that any Plan will provide any recovery for holders of Cineworld's existing equity interests.

Based on the current status of these discussions, Cineworld now expects to emerge from the Chapter 11 cases during the first half of 2023. Although any sale transaction resulting from the Marketing Process, among other things, may delay emergence beyond the first half of 2023, the Company remains committed to emerging from the Chapter 11 cases as expeditiously as possible.

Business as usual

As announced on 7 September 2022, during the restructuring process, Cineworld continues to operate its global business and cinemas as usual without interruption. Cineworld and its brands around the world - including Regal, Cinema City, Picture House and Planet - are continuing to welcome customers to cinemas as usual. The Group continues to honour the terms of all existing customer membership programmes, including Regal Unlimited and Regal Crown Club in the United States and Cineworld Unlimited in the UK.

Additional information

The person responsible for arranging the release of this announcement is Scott Brooker, Company Secretary.

For further information, please contact:

Cineworld Group plc Israel Greidinger Nisan Cohen Manuela Van Dessel investors@cineworld.co.uk +44 (0) 20 8987 5000

FGS Global (UK) James Leviton / James Thompson Cineworld-LON@fgsglobal.com +44 (0) 20 7251 3801

FGS Global (US) Kal Goldberg / Lizzie Hyland / Michael Mittelman +1 (646) 970-4727 CineworldMedia@fgsglobal.com

About Cineworld

Cineworld was founded in 1995 and is now one of the leading cinema groups in Europe. Originally a private company, it re-registered as a public company in May 2006 and listed on the London Stock Exchange plc in May 2007. Cineworld's acquisition of Regal Entertainment Group has created the second largest cinema business in the world (by number of screens). Cineworld currently operates in the United Kingdom, Ireland, Poland, the Czech Republic, Slovakia, Hungary, Bulgaria, Romania, Israel and the United States.

Forward looking statements

This announcement is not intended to and does not constitute and should not be construed as, considered a part of, or relied on in connection with any information or offering memorandum, security purchase agreement, or offer, invitation or recommendation to underwrite, buy, subscribe for, otherwise acquire, or sell any securities or other financial instruments or interests or any other transaction.

This announcement contains certain forward-looking statements with respect to the financial condition, results of operations and business of the Group and certain plans and objectives with respect thereto, including with respect to the Group's ordinary shares. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "hope", "aims", "continue", "will", "may", "should", "would", "could", or other words of similar meaning. These statements are based on assumptions and assessments made by the Group in light of their experience and their perception of historical trends, current conditions, future developments and other factors the Group believes appropriate. By their nature, forward-looking statements involve risk and uncertainty, because they relate to events and depend on circumstances that will occur in the future and the factors described in the context of such forward-looking statements in this document could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and you are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this document. The Group does not assume any obligation to update or correct the information contained in this document (whether as a result of new information, future events or otherwise), except as required by applicable law.

There are several factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are changes in the global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates and future business combinations or dispositions (including any potential sale by the Group) and the risks, uncertainties and costs related to the Chapter 11 cases, including, among others, the timing of any emergence from the Chapter 11 cases and the risk that any Plan may not be confirmed or implemented at all.

Nothing in this announcement is intended as a profit forecast or estimate for any period and no statement in this announcement should be interpreted to mean that earnings, profit or earnings or profit per share or dividend per share for the Group for the current or future financial years would necessarily match or exceed the historical published earnings, profit or earnings or profit per share or dividend per share for the Group.

PJT Partners LP, Alix Partners LLP, Kirkland & Ellis LLP and Slaughter and May (collectively, the "Advisers") are providing advice to Cineworld (and other members of the Group) and no one else in connection with the matters referred to in this announcement. The Advisers will not regard any other person as their client in connection with such matters, nor will they be responsible to any other person for providing the protections afforded to their clients or for providing advice in relation to such matters.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFXLLLXLLLBBK
Date   Source Headline
31st Jul 20233:10 pmRNSEntry of Cineworld Group plc into Administration
28th Jul 20237:30 amRNSSuspension - Cineworld Group PLC
28th Jul 20237:00 amRNSSuspension of Cineworld’s Listing
29th Jun 20237:00 amRNSConfirmation of Plan of Reorganisation
26th Jun 20239:50 amRNSDirector Declaration
26th Jun 20237:00 amRNSChapter 11 Update
25th May 20237:00 amRNSChapter 11 update
9th May 202312:24 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th Apr 202311:15 amRNSGeneral Meeting
18th Apr 20237:00 amRNSChapter 11 Update
11th Apr 20237:00 amRNSChapter 11 Update
3rd Apr 20237:00 amRNSChapter 11 Update
23rd Mar 20232:58 pmRNSNotice of General Meeting
9th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20234:35 pmRNSPrice Monitoring Extension
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20237:00 amRNSUpdate on Chapter 11 cases
1st Feb 20234:35 pmRNSPrice Monitoring Extension
27th Jan 202312:49 pmRNSCommittee Changes
3rd Jan 20237:00 amRNSUpdate on Chapter 11 cases and marketing process
14th Dec 20221:00 pmRNSDirectorate Change
12th Dec 20225:32 pmRNSDirector Update
8th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Nov 20229:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Nov 20224:40 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
28th Oct 20224:41 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
14th Oct 20224:41 pmRNSSecond Price Monitoring Extn
14th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim Results for the period ended 30 June 2022
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:35 pmRNSPrice Monitoring Extension
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20222:17 pmRNSUpdate Regarding Interim Results
20th Sep 20227:00 amRNSHolding(s) in Company
15th Sep 20229:33 amRNSHolding(s) in Company
15th Sep 20227:15 amRNSDirector Declaration
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:41 pmRNSSecond Price Monitoring Extn
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20228:21 amRNSReceives Court Approval for “First Day” Relief
8th Sep 20225:30 pmRNSCineworld Group
7th Sep 20223:45 pmRNSCommencement of Chapter 11 Cases
1st Sep 20229:54 amRNSStandard form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.